Large-cohort molecular profiling studies identified that, in GBM patients, there are frequent genetic aberrations in a specific set of genes, such as EGFR, CDKN2A/B, RB1, TP53, IDH1, NF1, PTEN, and PDGFRA4,5. Here, TP53 is linked to glioblastoma.